Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A

Changing paradigm of prophylaxis with longer acting factor concentrates

(2014) M. Carcao   HAEMOPHILIA

Variable Contributions of Basic Residues Forming an APC Exosite in the Binding and Inactivation of Factor VIIIa

(2013) Masahiro Takeyama et al.   BIOCHEMISTRY

Impact of being underweight or overweight on factor VIII dosing in hemophilia A patients

(2013) S. Henrard et al.   HAEMATOLOGICA

von Willebrand factor contributes to longer half-life of PEGylated factor VIIIin vivo

(2013) L. Tang et al.   HAEMOPHILIA

Long-lasting recombinant factor VIII proteins for hemophilia A

(2013) A. D. Shapiro   Hematology-American Society of Hematology Education Program

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

(2011) S. Bjorkman et al.   BLOOD

Function of the activated protein C (APC) autolysis loop in activated FVIII inactivation

(2011) Thomas J. Cramer et al.   BRITISH JOURNAL OF HAEMATOLOGY

Body weight and fat mass index as strong predictors of factor VIII in vivo recovery in adults with hemophilia A

(2011) S. HENRARD et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Evaluation of the TCIWorks Bayesian computer program for estimation of individual pharmacokinetics of FVIII

(2010) S. BJÖRKMAN   HAEMOPHILIA

Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring

(2010) S. BJÖRKMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Pharmacokinetics and dose requirements of factor VIII over the age range 3–74 years

(2009) Sven Björkman et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens

(2009) P. W. COLLINS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Models for Prediction of Factor VIII Half-Life in Severe Haemophiliacs: Distinct Approaches for Blood Group O and Non-O Patients

(2009) Kathelijn Fischer et al.   PLoS One

Plasma and albumin-free recombinant factorVIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients

(2008) V. S. BLANCHETTE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS